John E Bishop
CIK 1308911 · See Remarks · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.35M
Companies
4
Total Filings
134
Lifetime Open-Market Net
-$6.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | See Remarks | 336,845 | $4.00 | $1.35M | -$33.0K | 3 | 2026-05-22 |
| Lyra Therapeutics, Inc. (LYRA) Delisted | Chief Technology Officer | — | $0.70 | — | $0 | 2 | 2024-02-01 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | SVP, Chief Technology Officer | 0 | $20.01 | $0 | $0 | 3 | 2022-10-14 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Senior VP, Pharmaceutical Scie | 157,640 | — | — | -$6.40M | 124 | 2016-05-23 |
Recent Filings · Page 11 of 14
134 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-09-17 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −852 | -$13.0K | EDGAR |
| 2010-08-30 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −284 | -$4.7K | EDGAR |
| 2010-08-26 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −310 | -$4.7K | EDGAR |
| 2010-08-25 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | −2,498 | -$40.2K | EDGAR |
| 2010-07-27 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | −67,950 | -$1.41M | EDGAR |
| 2010-06-18 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | −2,498 | -$37.2K | EDGAR |
| 2010-06-18 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −429 | -$5.9K | EDGAR |
| 2010-06-16 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −426 | -$6.0K | EDGAR |
| 2010-05-28 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −284 | -$3.5K | EDGAR |
| 2010-05-27 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −314 | -$3.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.